Answers are grounded in this paper and cite their sources.
Flurbiprofen has been compared with phenylbutazone in a double-blind study involving 33 patients with acute gout. Patients received either flurbiprofen 400 mg daily for 48 h followed by 200 mg daily, or phenylbutazone 800 mg daily for 48 h followed by 400 mg daily. The drugs were of comparable efficacy, while side-effects were uncommon and relatively mild. Flurbiprofen appears to be a satisfactory alternative to phenylbutazone in the management of acute gouty arthritis.
No takes yet. Share an insight, caveat, or question.
Rc et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: